News – Page 166 – Endpoints News

FDA asks for more data on Dupixent in COPD in move that could delay a decision

Last year

Avid Bio fielding client inquiries due to China bill; Oxford Bio wants to double its revenues

Last year

Context Therapeutics' $100M placement; Blueprint raises guidance for rare disease drug

Last year

As it cuts costs and pipeline, Bristol Myers hands back a cancer drug to Schrödinger

Last year

Novartis makes a $1B radiopharma deal, buying Mariana Oncology

Last year

Biotech vets raise $67M to develop targeted activators for cancer

Last year

BridgeBio spins out oncology unit with $200M in backing for RAS assets

Last year

A once-public psychedelic biotech reemerges with $103M from MPM and Novo Holdings

Last year

Exclusive: Spark co-founder launches new CNS gene therapy biotech with $54M

Last year

Novo’s GLP-1 sales boost profits, yet full potential still curbed by supply squeeze

Last year

FDA decision on Sarepta’s Duchenne gene therapy could come earlier than expected

Last year

Epigenetic editing startup Chroma lays off staff, focusing on reaching the clinic

Last year

CVS is getting pummeled by the very strategy it once planned its future on

Last year

J&J follows Bristol Myers in appeal of judge's ruling against companies in IRA lawsuit

Last year

Pfizer sticks to the script in first-quarter update as cost cuts are 'largely complete'

Last year

Boehringer puts a target on Humira, says pushing it off formularies is necessary

Last year

J&J proposes $6.5B talc settlement plan

Last year

Senator alleges GSK is shirking its commitment to lower inhaler costs

Last year

Is UnitedHealth Group too big? Senators grill CEO on key question in wake of cyberattack

Last year

GSK expedites Blenrep timelines as it eyes second chance in multiple myeloma

Last year

Editas, BMS extend T cell deal; KalVista seeks partner for preclinical HAE program

Last year

Astellas taps Poseida for second CAR-T deal focused on solid tumors

Last year

GSK still riding vaccine sales wave, pushing 2024 forecasts higher

Last year

Pfizer makes small pipeline changes in first-quarter update

Last year

First page Previous page 163 164 165166167 168 169 Next page Last page